A Co-localized Hepatitis C Virus Clinic in a Primary Care Practice Improves Linkage to Care in a High Prevalence Population

We report the Hepatitis C prevalence and evaluate the impact of the integrated clinic on the Hepatitis C cascade of care.
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Clinical Research Study Source Type: research

Related Links:

Conditions:   Hepatitis C;   Telemedicine Intervention:   Other: Telemedicine Sponsor:   University of La Laguna Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 1 June 2020Source: Journal of Hospital InfectionAuthor(s): Carlo Balmelli, Giorgio Merlani, Gladys Martinetti, Danuta Reinholz, Stefania Paolucci, Fausto Baldanti, Antonio Piralla, Filippo Del Grande, Enos Bernasconi
Source: Journal of Hospital Infection - Category: Infectious Diseases Source Type: research
In conclusion, the world of psychiatry is a possible hidden reservoir of HCV and, as such, a part of the challenge for eliminating the virus. Patients, families, and caregivers will have to be correctly sensitized and trained to play their role in the process. Specific investigations will be required to better understand why such an increased prevalence of HCV is observed in this population. Specific adaptations of the cascade of care within psychiatric settings, including access to treatment, will need to be designed, implemented, and evaluated for reaching micro-elimination of HCV in psychiatry. PMID: 32473777 [PubMe...
Source: L Encephale - Category: Psychiatry Tags: Encephale Source Type: research
Journal of Interferon&Cytokine Research, Ahead of Print.
Source: Journal of Interferon - Category: Research Authors: Source Type: research
Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis worldwide and kills more Americans than 59 other infections, including HIV and tuberculosis, combined. While direct-acting antiviral (DAA) treatments are effective, limited uptake of therapy, particularly in high-risk groups, remains a substantial barrier to eliminating HCV. We developed...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Physical Sciences Source Type: research
Dalton Trans., 2020, Accepted Manuscript DOI: 10.1039/D0DT01408G, PaperSheta Mohamed Sheta, Said M. El-Sheikh, Diaa I. Osman, Aliaa M.S. Salem, Omnia Ali, Farid A Harraz, Wafaa Gh Shousha, Madiha Shoeib, Sherif Shawky, Dionysios D. Dionysiou Hepatitis-C virus ribonucleic acid (HCV-RNA) recognition and quantification based on real-time polymerase chain reaction (RT- PCR) is the main pillar in infection control, management, and response to treatment due to... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Dalton Trans. latest articles - Category: Chemistry Authors: Source Type: research
Publication date: Available online 30 May 2020Source: American Journal of Kidney DiseasesAuthor(s): Kristen L. King, S. Ali Husain, Sumit Mohan
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
We thank Nabatchikova et  al.1 and Shiba et al.2 for their interest and comments on our work.3 First, we would like to explain that the main reason for predicting an event (hepatocellular carcinoma [HCC] in this case) is to guide future action (for example HCC screening). In our study, our initial aim was to identify a su bpopulation of patients with compensated advanced chronic liver disease (cACLD), in whom HCV had been cured, who could avoid HCC surveillance; unfortunately, we failed. All HCV-cured patients with cACLD need continued HCC screening.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research
We read with great interest the article by M. Pons and colleagues in which they estimated the incidence of liver-related events and predictive ability of non-invasive markers of liver fibrosis after successful antiviral therapy for HCV infection.1 In this prospective 2 center study from Spain, including patients with HCV-related compensated advanced chronic liver disease (liver stiffness (LS) ≥10 kPa), hepatocellular carcinoma (HCC) developed in 4.4% (25/572) of cases within 2.8 years of the end of treatment (EOT).
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research
Hepatitis B virus (HBV) is a virus species belonging to Hepadnaviridae family which is partial double-stranded DNA viruses (Pourkarim et al., 2014). This virus affects nearly 2 billion people around the world (Wang et al., 2019) and it has been reported as one of the two major causing and risk factors (the second is Hepatitis C Virus) for hepatocellular carcinoma (HCC) in the Sudan (Abou et al., 2009). Several studies have characterized HBV as extremely endemic in Sudan as the hepatitis B surface antigen HBsAg was reported to have a prevalence of approximately 16%-20% in the Sudanese population rate (Elduma and Saeed, 2011).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
More News: General Medicine | Hepatitis | Hepatitis C | Primary Care | Primary Care Practices | Study